Arno Therapeutics Inc. (ARNI) OTC MARKETS

$0 - (-)

Market Cap: $14805

As of 04/23/24 12:00 AM EDT. Market open.

(ARNI)

Arno Therapeutics Inc. (ARNI)
OTC MARKETS

$0
- (-)

Market Cap: $14805

As of 04/23/24 12:00 AM EDT. Market open.

Add to Portfolio

arno therapeutics inc (arni) is a pharmaceuticals company located in 4 campus drive, 2nd floor, parsippany, nj, united ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Alexander Zukiwski
Full Time Employees
4
URL
Address
200 State Route 31 Ste 104, New Jersey, Flemington, 08822-5812.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Alexander Zukiwski
Full Time Employees
4
URL
Address
200 State Route 31 Ste 104, New Jersey, Flemington, 08822-5812.
PRICE CHART FOR ARNO THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0
Days Range
- - -
52 week range
$0 - $0
Volume
3,500
Avg. Volume (30 days)
3,500
Market Cap
$14805
Dividend Yield
-
P/E
-
Shares Outstanding
49,349,749
Open
-
Previous Close
$0
Days Range
- - -
52 week range
$0 - $0
Volume
3,500
Avg. Volume (30 days)
3,500
Market Cap
$14805
Dividend Yield
-
P/E
-
Shares Outstanding
49,349,749
FINANCIAL STATEMENTS FOR ARNO THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ARNO THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Kariv TomerDirectorJan 12, 2016 Buy$0.35206,98672,445393,968Apr 11, 2016, 04:22 PM
Kariv TomerDirectorJan 12, 2016 Buy$0.35533,208186,6231,014,888Apr 11, 2016, 04:22 PM
Kariv TomerDirectorJan 12, 2016 Buy$0.35707,868247,7541,347,327Apr 11, 2016, 04:22 PM
Ruchefsky Steven BDirectorJan 12, 2016 Buy$0.352,876,6331,006,8224,472,905Jan 14, 2016, 05:20 PM
Zukiwski Alexander AVP & Chief Medical OfficerJan 12, 2016 Buy$0.35144,80650,682261,832Jan 14, 2016, 05:20 PM
TANEN DAVID MSecretaryJan 12, 2016 Buy$0.35362,015126,705362,015Jan 14, 2016, 05:20 PM
Belldegrun ArieDirectorJan 12, 2016 Buy$0.35714,285250,000858,094Jan 14, 2016, 05:19 PM
Belldegrun ArieDirectorJan 12, 2016 Buy$0.351,448,062506,8221,548,543Jan 14, 2016, 05:19 PM
Kariv TomerDirectorJan 12, 2016 Buy$0.35206,98672,445393,968Jan 14, 2016, 05:19 PM
Kariv TomerDirectorJan 12, 2016 Buy$0.35533,208186,6231,014,888Jan 14, 2016, 05:19 PM
Kariv TomerDirectorJan 12, 2016 Buy$0.35707,868247,7541,347,327Jan 14, 2016, 05:19 PM
Belldegrun ArieDirectorOct 29, 2013 Option Exercise$2.406,66615,998100,481Nov 05, 2013, 10:08 AM
Belldegrun ArieDirectorOct 29, 2013 Option Exercise$2.405,00012,00091,312Nov 05, 2013, 10:08 AM
Belldegrun ArieDirectorOct 29, 2013 Option Exercise$2.4066,652159,96586,312Nov 05, 2013, 10:08 AM
Belldegrun ArieDirectorOct 29, 2013 Option Exercise$2.4088,871213,29093,815Nov 05, 2013, 10:08 AM
Belldegrun ArieDirectorOct 29, 2013 Option Exercise$2.4011,66627,998191,794Nov 05, 2013, 10:08 AM
Belldegrun ArieDirectorOct 29, 2013 Option Exercise$2.4010,00024,000150,721Nov 05, 2013, 10:08 AM
Belldegrun ArieDirectorOct 29, 2013 Option Exercise$2.40155,523373,255180,128Nov 05, 2013, 10:08 AM
Belldegrun ArieDirectorOct 29, 2013 Option Exercise$2.40133,305319,932140,721Nov 05, 2013, 10:08 AM
Zukiwski Alexander AVP & Chief Medical OfficerOct 29, 2013 Option Exercise$2.405,00012,00075,360Oct 31, 2013, 07:53 PM
Zukiwski Alexander AVP & Chief Medical OfficerOct 29, 2013 Option Exercise$2.4066,652159,96570,360Oct 31, 2013, 07:53 PM
Proniuk StefanVP of Product DevelopmentOct 29, 2013 Option Exercise$2.406661,59810,047Oct 31, 2013, 07:40 PM
Proniuk StefanVP of Product DevelopmentOct 29, 2013 Option Exercise$2.408,88721,3299,381Oct 31, 2013, 07:40 PM
Ruchefsky Steven BDirectorOct 29, 2013 Option Exercise$2.4041,66699,9981,596,272Oct 31, 2013, 07:38 PM
Ruchefsky Steven BDirectorOct 29, 2013 Option Exercise$2.40555,4401,333,056867,106Oct 31, 2013, 07:38 PM
Mattes Glenn R.President & CEOOct 29, 2013 Option Exercise$2.401,6663,99856,370Oct 31, 2013, 07:36 PM
Mattes Glenn R.President & CEOOct 29, 2013 Option Exercise$2.4022,21853,32354,704Oct 31, 2013, 07:36 PM
Kariv TomerDirectorOct 29, 2013 Option Exercise$2.404,76411,434127,424Oct 31, 2013, 07:33 PM
Kariv TomerDirectorOct 29, 2013 Option Exercise$2.4012,27429,458328,254Oct 31, 2013, 07:33 PM
Kariv TomerDirectorOct 29, 2013 Option Exercise$2.4016,29439,106435,777Oct 31, 2013, 07:33 PM
Kariv TomerDirectorOct 29, 2013 Option Exercise$2.4063,516152,438122,660Oct 31, 2013, 07:33 PM
Kariv TomerDirectorOct 29, 2013 Option Exercise$2.40163,620392,688315,980Oct 31, 2013, 07:33 PM
Kariv TomerDirectorOct 29, 2013 Option Exercise$2.40217,216521,318419,483Oct 31, 2013, 07:33 PM
WEXFORD CAPITAL LPNo longer own 10% of IssuerOct 04, 2013 Sale$0.483251562,827,844Oct 09, 2013, 05:31 PM
Kariv TomerDirectorMay 28, 2013 Option Exercise$0.309,5292,859473,156Jun 05, 2013, 04:05 PM
Kariv TomerDirectorMay 28, 2013 Option Exercise$0.3024,5487,3641,218,883Jun 05, 2013, 04:05 PM
Kariv TomerDirectorMay 28, 2013 Option Exercise$0.3032,5899,7771,618,140Jun 05, 2013, 04:05 PM
Ruchefsky Steven BDirectorMay 28, 2013 Option Exercise$0.3080,55624,1672,493,331Jun 04, 2013, 04:16 PM
Belldegrun ArieDirectorMay 28, 2013 Option Exercise$0.3022,5566,767196,841Jun 03, 2013, 04:46 PM
Belldegrun ArieDirectorMay 28, 2013 Option Exercise$0.3019,3335,80059,333Jun 03, 2013, 04:46 PM
Belldegrun ArieDirectorMay 28, 2013 Option Exercise$0.3012,8893,86739,555Jun 03, 2013, 04:46 PM
Belldegrun ArieDirectorMay 28, 2013 Option Exercise$0.309,6672,900157,286Jun 03, 2013, 04:46 PM
Zukiwski Alexander AVP & Chief Medical OfficerMay 28, 2013 Option Exercise$0.309,6672,90029,667May 30, 2013, 05:05 PM
Proniuk StefanVP of Product DevelopmentMay 28, 2013 Option Exercise$0.301,2893873,955May 30, 2013, 05:04 PM
Mattes Glenn R.President & CEOMay 28, 2013 Option Exercise$0.303,222967259,888May 30, 2013, 05:02 PM
THURMAN RANDY HDirectorMay 22, 2013 Buy$0.502,5001,25010,000May 23, 2013, 04:57 PM
THURMAN RANDY HDirectorMay 21, 2013 Buy$0.507,5003,7507,500May 23, 2013, 04:57 PM
Ruchefsky Steven BDirectorApr 29, 2013 Option Exercise$0.3083,33325,0002,412,775May 07, 2013, 01:05 PM
Belldegrun ArieDirectorApr 29, 2013 Option Exercise$0.3013,3334,00026,666May 07, 2013, 12:20 PM
Belldegrun ArieDirectorApr 29, 2013 Option Exercise$0.3010,0003,000147,619May 07, 2013, 12:20 PM
Belldegrun ArieDirectorApr 29, 2013 Option Exercise$0.3023,3337,000174,285May 07, 2013, 12:20 PM
Belldegrun ArieDirectorApr 29, 2013 Option Exercise$0.3020,0006,00040,000May 07, 2013, 12:20 PM
Mattes Glenn R.President & CEOApr 29, 2013 Option Exercise$0.303,3331,000256,666May 07, 2013, 10:12 AM
Zukiwski Alexander AVP & Chief Medical OfficerApr 29, 2013 Option Exercise$0.3010,0003,00020,000May 07, 2013, 09:15 AM
Kariv TomerDirectorApr 29, 2013 Option Exercise$0.3016,2914,887463,627May 07, 2013, 09:14 AM
Kariv TomerDirectorApr 29, 2013 Option Exercise$0.3041,96712,5901,194,335May 07, 2013, 09:14 AM
Kariv TomerDirectorApr 29, 2013 Option Exercise$0.3055,71416,7141,585,551May 07, 2013, 09:14 AM
Proniuk StefanVP of Product DevelopmentApr 29, 2013 Option Exercise$0.301,3334002,666May 06, 2013, 05:10 PM
Belldegrun ArieDirectorMar 27, 2013 Option Exercise$0.3023,3337,000150,952Apr 15, 2013, 09:32 AM
Belldegrun ArieDirectorMar 27, 2013 Option Exercise$0.3020,0006,00020,000Apr 15, 2013, 09:32 AM
Belldegrun ArieDirectorMar 27, 2013 Option Exercise$0.3013,3334,00013,333Apr 15, 2013, 09:32 AM
Belldegrun ArieDirectorMar 27, 2013 Option Exercise$0.3010,0003,000137,619Apr 15, 2013, 09:32 AM
Zukiwski Alexander AVP & Chief Medical OfficerMar 27, 2013 Option Exercise$0.3010,0003,00010,000Apr 11, 2013, 02:01 PM
Proniuk StefanVP of Product DevelopmentMar 27, 2013 Option Exercise$0.301,3334001,333Apr 10, 2013, 10:30 AM
Kariv TomerDirectorMar 27, 2013 Option Exercise$0.309,5292,859447,336Apr 10, 2013, 09:51 AM
Kariv TomerDirectorMar 27, 2013 Option Exercise$0.3024,5487,3641,152,368Apr 10, 2013, 09:51 AM
Kariv TomerDirectorMar 27, 2013 Option Exercise$0.3032,5899,7771,529,837Apr 10, 2013, 09:51 AM
Ruchefsky Steven BDirectorMar 27, 2013 Option Exercise$0.3083,33325,0002,329,442Apr 09, 2013, 05:46 PM
Mattes Glenn R.President & CEOMar 27, 2013 Option Exercise$0.303,3331,000253,333Apr 09, 2013, 05:40 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Kariv TomerDirector01/12/201672,445
Kariv TomerDirector01/12/2016186,623
Kariv TomerDirector01/12/2016247,754
Ruchefsky Steven BDirector01/12/20161,006,822
Zukiwski Alexander AVP & Chief Medical Officer01/12/201650,682
TANEN DAVID MSecretary01/12/2016126,705
Belldegrun ArieDirector01/12/2016250,000
Belldegrun ArieDirector01/12/2016506,822
Kariv TomerDirector01/12/201672,445
Kariv TomerDirector01/12/2016186,623
Kariv TomerDirector01/12/2016247,754
Belldegrun ArieDirector10/29/201315,998
Belldegrun ArieDirector10/29/201312,000
Belldegrun ArieDirector10/29/2013159,965
Belldegrun ArieDirector10/29/2013213,290
Belldegrun ArieDirector10/29/201327,998
Belldegrun ArieDirector10/29/201324,000
Belldegrun ArieDirector10/29/2013373,255
Belldegrun ArieDirector10/29/2013319,932
Zukiwski Alexander AVP & Chief Medical Officer10/29/201312,000
Zukiwski Alexander AVP & Chief Medical Officer10/29/2013159,965
Proniuk StefanVP of Product Development10/29/20131,598
Proniuk StefanVP of Product Development10/29/201321,329
Ruchefsky Steven BDirector10/29/201399,998
Ruchefsky Steven BDirector10/29/20131,333,056
Mattes Glenn R.President & CEO10/29/20133,998
Mattes Glenn R.President & CEO10/29/201353,323
Kariv TomerDirector10/29/201311,434
Kariv TomerDirector10/29/201329,458
Kariv TomerDirector10/29/201339,106
Kariv TomerDirector10/29/2013152,438
Kariv TomerDirector10/29/2013392,688
Kariv TomerDirector10/29/2013521,318
WEXFORD CAPITAL LPNo longer own 10% of Issuer10/04/2013156
Kariv TomerDirector05/28/20132,859
Kariv TomerDirector05/28/20137,364
Kariv TomerDirector05/28/20139,777
Ruchefsky Steven BDirector05/28/201324,167
Belldegrun ArieDirector05/28/20136,767
Belldegrun ArieDirector05/28/20135,800
Belldegrun ArieDirector05/28/20133,867
Belldegrun ArieDirector05/28/20132,900
Zukiwski Alexander AVP & Chief Medical Officer05/28/20132,900
Proniuk StefanVP of Product Development05/28/2013387
Mattes Glenn R.President & CEO05/28/2013967
THURMAN RANDY HDirector05/22/20131,250
THURMAN RANDY HDirector05/21/20133,750
Ruchefsky Steven BDirector04/29/201325,000
Belldegrun ArieDirector04/29/20134,000
Belldegrun ArieDirector04/29/20133,000
Belldegrun ArieDirector04/29/20137,000
Belldegrun ArieDirector04/29/20136,000
Mattes Glenn R.President & CEO04/29/20131,000
Zukiwski Alexander AVP & Chief Medical Officer04/29/20133,000
Kariv TomerDirector04/29/20134,887
Kariv TomerDirector04/29/201312,590
Kariv TomerDirector04/29/201316,714
Proniuk StefanVP of Product Development04/29/2013400
Belldegrun ArieDirector03/27/20137,000
Belldegrun ArieDirector03/27/20136,000
Belldegrun ArieDirector03/27/20134,000
Belldegrun ArieDirector03/27/20133,000
Zukiwski Alexander AVP & Chief Medical Officer03/27/20133,000
Proniuk StefanVP of Product Development03/27/2013400
Kariv TomerDirector03/27/20132,859
Kariv TomerDirector03/27/20137,364
Kariv TomerDirector03/27/20139,777
Ruchefsky Steven BDirector03/27/201325,000
Mattes Glenn R.President & CEO03/27/20131,000
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ARNO THERAPEUTICS INC
LOADING...